Aveo Pharmaceuticals, Inc.
Clinical trials sponsored by Aveo Pharmaceuticals, Inc., explained in plain language.
-
New drug combo aims to extend life in Tough-to-Treat head and neck cancer
Disease control Recruiting nowThis phase 3 study tests whether adding ficlatuzumab to standard cetuximab helps people with recurrent or metastatic HPV-negative head and neck cancer live longer or keep their cancer from growing. About 410 adults with confirmed disease and at least one measurable tumor will be …
Phase: PHASE3 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New drug aims to reverse wasting in cancer patients
Symptom relief Recruiting nowThis early-stage trial tests a drug called AV-380 in 30 adults with advanced cancer who are losing weight and muscle (cachexia) and have high levels of a protein called GDF-15. The drug is given alongside standard chemotherapy to see if it is safe and how the body processes it. T…
Phase: PHASE1 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC